You are here

  • Home
  • Archive
  • Volume 68, Issue 8
  • Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A–677C alleles on probability to respond

Article Text

Article menu
Download PDFPDF
Letter
Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A–677C alleles on probability to respond

https://doi.org/10.1136/ard.2008.096891

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: None.

    • Funding: The Foundation Nuts Ohra (Amsterdam) and Schering-Plough BV contributed to this work financially.

    • Ethics approval: Ethics approval was obtained from Leiden University Medical Centre, Leiden, The Netherlands.